Here are relevant reports on : patient-adherence-market
-
Veterinary Medical Devices and Supplies Market by Product (Anesthesia, Patient Monitoring, Infusion Pumps, Consumables), Application (Diagnosis, Monitoring, Therapy, Surgical), Animal Type (Companion Animals, Large Animals) - Global Forecast to 2030
The global veterinary medical devices and supplies market, valued at US$2.50 billion in 2024, stood at US$2.66 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$3.60 billion by the end of the period. The market growth is driven by the rising pet ownership and increasing expenditure on animal healthcare, coupled with the growing prevalence of chronic and infectious diseases in companion and livestock animals.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Europe Patient Engagement Solutions Market by Therapy (Chronic [CVD, Obesity], Women's Health), Functionality (Telehealth, E-Prescribing, Scheduling, Billing, Education), End User (Hospitals, ASCs, Payers, Patients) - Forecast to 2030
The Europe Patient Engagement Solutions market, valued at USD 6.42 billion in 2024, stood at USD 7.35 billion in 2025 and is projected to advance at a resilient CAGR of 12.7% from 2025 to 2030, culminating in a forecasted valuation of USD 13.37 billion by the end of the period. This development is fueled by the changing trend toward value-based and outcome-oriented care, escalating the need to provide continuous interaction with patients outside of clinical care, and an increasing use of digital front-door solutions (patient portals and virtual assistants).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Patient Positioning Systems Market Size by Product (Tables (Surgical Table, Imaging Table, Examination Table), Accessories, Application (Surgery, Diagnosis, Cancer Treatment), End User (Hospitals, ASCs, Diagnostic Labs)) & Region - Global Forecast to 2027
The global patient positioning systems market growth is primed to transition from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, showcasing a strong CAGR of 4.0%. Growth of the market is attributed to the increasing preference for minimally invasive surgeries and rising funding for new healthcare facility establishment.
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
Medical Furniture Market By Product [Medical Beds (Electric, Manual), Chairs (Gynecology, Bariatric), Tables, Cabinets, Trolleys], By Application [Long-term, Patient Care & Accommodation], End User [Hospitals, ASCs], By Region - Global Forecast to 2031
The Medical Furniture market, valued at US$13.43 billion in 2025, stood at US$14.02 billion in 2026 and is projected to advance at a resilient CAGR of 5.4% from 2026 to 2031, culminating in a forecasted valuation of US$18.21 billion by the end of the period. The growth of the medical furniture market is driven by the expanding healthcare infrastructure, rising hospitalization rates, increasing chronic disease burden, and growing demand for advanced, ergonomic, and patient-centric care environments across hospitals, ASCs, and long-term care facilities.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Parkinson's Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics) - Global Forecast to 2022
The Parkinson's disease treatment market is expected to reach USD 5.69 Billion by 2022 from USD 4.24 Billion in 2017, at a CAGR of 6.1%. The market is being driven by the growth in aging population and the associated increase in the prevalence of Parkinson’s disease and government funding for research. Some of the major players operating in the Parkinson’s disease treatment market include Teva (Israel), Novartis AG (Switzerland), GSK (UK), AbbVie (US), Merck (US), Boehringer Ingelheim (Germany), Impax Laboratories (US), Lundbeck (Denmark), Sun Pharma (India), Wockhardt (India), UCB (Belgium), Valeant Pharmaceuticals (Canada), and Acadia (US).
- Published: October 2017
- Price: $ 4950
- TOC Available:
-
Patient Portal Market by Type (Standalone, and Integrated portal), by Delivery Mode (Web-Based, and Cloud- Based), & by End Users (Providers, Payers, Pharmacies, and Others) - Global Forecast to 2020
The patient portal market size is projected to grow at a CAGR of 18.1%. The market is projected to be dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The European region is projected to grow at the highest rate during the forecast period.
- Published: March 2016
- Price: $ 4950
- TOC Available:
-
Urinary Incontinence Devices Market by Product (Urinary Catheters (Indwelling Catheters, Intermittent Catheters), Artificial Urinary Sphincters), Incontinence Type (Stress), Patient Type (Male, Female), End User (Hospitals) - Global Forecast to 2030
Global urinary incontinence devices market valued at $3.82B in 2023, reached $4.22B in 2024, and is projected to grow at a robust 11.2% CAGR, hitting $7.97B by 2030. As aging is a major risk factor for urinary incontinence, countries with a growing elderly population are witnessing a higher demand for effective incontinence management solutions.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Resuscitation Devices Market by Product (Defibrillator, Endotracheal & Tracheostomy Tube, Masks, Airways, Laryngoscopes, Resuscitators, Ventilators), Patient Type (Neonatal, Adult), End User (Hospital, Ambulance, ICU), Volume & Region - Global Forecasts to 2025
The global resuscitation devices market in terms of revenue was estimated to be worth $6.9 billion in 2020 and is poised to reach $8.7 billion by 2025, growing at a CAGR of 4.7% from 2020 to 2025. Prominent players in this market includes Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), ZOLL Medical Corporation (US), ResMed Inc. (US), Physio-Control (acquired by Stryker Corporation) (US), Drägerwerk AG & Co. KGaA (Germany), Smiths Medical (US), Ambu (Denmark), Cardinal Health (US), Mindray Medical (China), Nihon Kohden (Japan), Teleflex (US), Salter Labs (US), GE Healthcare (US), Roper Technologies (US), Vyaire Medical (US), Intersurgical (UK), 3M (US), Flexicare (UK), and KARL STORZ (Germany).
- Published: March 2020
- Price: $ 4950
- TOC Available:
-
Trauma Simulation Market by Offering (Patient [High-fidelity], Application [Polytrauma, Airway, Hemorrhage]), Trainers, Surgical [Laparoscopic, Ortho, Spine]), Technology (Virtual, 3D), End User (Academic, Hospitals, Military) - Global Forecast to 2030
The Trauma Simulation market, valued at US$0.45 billion in 2024, stood at US$0.50 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$0.73 billion by the end of the period. The trauma simulation market is growing, fueled by the increasing use of high-fidelity patient simulators, immersive VR/AR platforms, and AI-driven scenarios that enable realistic physiological modeling, adaptive case progression, and collaborative trauma training.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Patient Temperature Monitoring Market by Product (Wearable, Continuous, Digital Thermometer, Infrared Thermometer), Site (Non-invasive, Invasive), Application (Fever, Anesthesia, Hypothermia), End User (Hospital, ICU, Urgent Care) - Global Forecast to 2032
The global patient temperature monitoring market, valued at US$2.31 billion in 2024, stood at US$2.44 billion in 2025 and is projected to advance at a resilient CAGR of 6.7% from 2025 to 2032, culminating in a forecasted valuation of US$3.85 billion by the end of the period. The patient temperature monitoring market is experiencing substantial growth due to several pivotal factors. Key drivers include a burgeoning global population and an escalating incidence of infectious diseases.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
